Jared Heyman

Jared Heyman is an American entrepreneur who founded the online survey company Infosurv.[1][2][3] He has a business degree from the University of Texas and holds two US patents.[4][5]

Jared Heyman
NationalityAmerican
EducationBusiness degree from University of Texas
OccupationEntrepreneur
TitleFounder of Infosurv
CEO & Founder of CrowdMed

While studying at the University of Texas at Austin, Heyman had internships at Bain & Company and Collective Technologies, a small tech firm.[1] Jared Heyman graduated magna cum laude with a business degree.[4] He founded Infosurv in 1998 in Atlanta, Georgia.[1] Infosurv is an Internet survey company specializing in employee and customer surveys for market research purposes, which Heyman grew to over $20M in aggregate revenue.[1][2][6][7] In 2013, Infosurv spun out a new company called Intengo, which uses crowdsourcing techniques to help clients develop new ideas and go-to-market strategies.[8]

Jared Heyman then served as chief executive officer and founder of CrowdMed, established April 2013, which is a crowdsourcing platform where people submit medical cases and get suggested diagnosis information to take to their doctors.[2][3] The company was inspired by his sister who had a rare genetic disease that took three years to diagnose and has raised $4.2M in venture capital from Silicon Valley venture capital firms and individual investors including actor Patrick Dempsey, 23andMe founder Anne Wojcicki, and Y Combinator president Sam Altman[2][3][4][7][9] Heyman then served as a General Partner at Pioneer Fund, a venture capital fund that pools capital and expertise from 100+ Y Combinator alumni to support the next generation of YC startups and currently serves as Managing Partner of Rebel Fund, whose mission is “to leverage data science and Silicon Valley’s most accomplished founders to invest in a diversified portfolio of Y Combinator startups statistically powered to outperform”.[10][11]

In 2014, Heyman gave a TEDMED talk to reveal how crowd wisdom can help solve even the most elusive medical mysteries.[7] IHC reports that Heyman has been quoted or featured in hundreds of news articles[12]

References

  1. Manoj Jasra (January 31, 2007). "Interview – Infosurv President Jared Heyman". Web Analytics World. Retrieved April 18, 2015.
  2. Tom Fowler (May 7, 2014). "Crowdsourcing as a Medical Tool: Interview with CrowdMed CEO Jared Heyman". MedGadget. Retrieved April 18, 2015.
  3. Erica Dhawan (January 14, 2015). "How to Get Big Things Done in 2015". Forbes. Retrieved April 18, 2015.
  4. Mark Huffman (September 26, 2014). "People with mystery illnesses are finding answers in the crowd". ConsumerAffairs. Retrieved April 18, 2015.
  5. "Google Patent Search - Lee Jared Heyman".
  6. Mallory Leone (April 1, 2014). "Medical detectives deal in challenging diagnoses on CrowdMed's virtual stock market". MedCity News. Retrieved April 18, 2015.
  7. "Jared Heyman". TEDMED. Retrieved April 18, 2015.
  8. "New Crowdsourcing Firm Intengo Launches". mrweb. October 18, 2013. Retrieved March 19, 2016.
  9. "Patrick 'McDreamy' Dempsey Invests in Health Startup CrowdMed". WSJ. May 20, 2014.
  10. "Pioneer Fund team page".
  11. "Rebel Fund". Rebel Fund. Retrieved 2021-04-21.
  12. "2016 IHC FORUM & Expo - May 24-26, 2016 - Atlanta, Georgia". www.theihccforum.com. Retrieved 2016-08-11.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.